Timeline
Isabelle Staropoli
Research Engineer
07 Oct 2024
publication
Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting.
Read more30 Sep 2024
publication
Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP.3.3 From Approved Monoclonal Antibodies
Read more19 Jul 2024
publication
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2.
Read more13 Mar 2024
publication
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion.
Read more13 Dec 2023
28 Feb 2023
publication
Exposure to Secreted Bacterial Factors Promotes HIV-1 Replication in CD4+ T Cells.
Read more14 Feb 2023
publication
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.
Read more24 Jan 2023
01 Jan 2023
17 Nov 2022
publication
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies.
Read more05 Oct 2022
publication
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection.
Read more01 Sep 2022
publication
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.
Read more04 Jul 2022
publication
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Read more17 Jun 2022
news
New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Read more01 Jun 2022
publication
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies.
Read more12 Mar 2022
publication
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.
Read more01 Feb 2022
26 Jan 2022
publication
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry.
Read more01 Nov 2021
publication
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study.
Read more18 Aug 2021
01 Aug 2021
publication
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.
Read more08 Jul 2021
18 May 2021
publication
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
Read more01 Apr 2021
publication
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020
Read more01 Jan 2021
02 Sep 2020
publication
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
Read more01 Sep 2020
publication
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.
Read more06 Dec 2018
22 Nov 2016
publication
Guidelines for cloning, expression, purification and functional characterization of primary HIV-1 envelope glycoproteins
Read more03 Jul 2015
18 Jun 2015
publication
A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity
Read more11 May 2015
22 May 2014
publication
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry
Read more21 May 2013
publication
HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines
Read more26 Jan 2012
30 Nov 2010
publication
New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection
Read more02 Jul 2008
publication
The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins
Read more01 Jan 2007
01 Mar 2006
publication
Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells
Read more01 May 2005
publication
Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E
Read more26 Apr 2005
publication
Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals
Read more10 Mar 2005
publication
Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis
Read more27 Feb 2003
publication
DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2
Read more22 Nov 2002
publication
Low levels of co-receptor CCR5 are sufficient to permit HIV envelope-mediated fusion with resting CD4 T cells
Read more12 Nov 2002
publication
HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains
Read more26 Feb 2002
publication
Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4
Read more10 Nov 2000
publication
Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate
Read more01 Dec 1997
publication
Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice
Read more01 Feb 1996
publication
Dengue virus envelope glycoprotein can be secreted from insect cells as a fusion with the maltose-binding protein
Read more01 Jul 1994
publication